Leriglitazone has met the primary endpoint in NEXUS, the pivotal trial for pediatric pati... 11/12/2024 Healthcare Rare diseases Statistically significant difference in arrested disease in leriglitazone treated patients when compared to the natural... Partners - Minoryx Therapeutics
Corify Care secures €6 million to accelerate the expansion of its revolutionary non-invasi... 11/12/2024 Healthcare Advanced therapies Corify Care has secured €6 million in funding to expand its non-invasive cardiac mapping technology, ACORYS, aimed at... Partners - Corify Care
Eugin Group leads €3.5-million project to improve embryo implantation, a factor associate... 04/12/2024 Healthcare Advanced therapies The Eugin Group, from its Basic Research Centre at the Barcelona Science Park, is leading a consortium of 15 public and... Partners - Parc Científic de Barcelona
VIVEbiotech Secures Growth Investment from Ampersand Capital Partners to Expand Lentivira... 04/12/2024 Healthcare Personalized medicine VIVEbiotech, a company specializing in lentiviral vectors for gene and cell therapies, has received an investment from... Partners - VIVEbiotech
Rare Disease Summit Philadelphia USA Del 18/03/2025 to 20/03/2025 Healthcare Rare diseases International
18TH Annual European Life Sciences CEO Forum Zurich Switzerland Del 26/02/2025 to 27/02/2025 Healthcare International Financing
Clinical Data Disclosure, Transparency & Plain Language Summaries Philadelphia USA Del 25/02/2025 to 26/02/2025 Healthcare Industrial biotechnology International
EUCROF25 (European Clinical Research Conference) Copenhagen Denmark Del 02/02/2025 to 04/02/2025 Healthcare Industrial biotechnology International
8TH ANNUAL NEUROSCIENCE INNOVATION FORUM FOR BUSINESS DEVELOPMENT, LICENSING & INVESTMENT San Francisco United States Del 12/01/2025 to 12/01/2025 Healthcare Access to innovation International
World Orphan Drug Congress Europe 2025 Amsterdam Netherlands Del 27/10/2025 to 29/10/2025 Healthcare Drug discovery International
